Form 4: HCA Healthcare Executive Kathleen M. Whalen Sells 1,474 Shares

HCA Healthcare's Senior Vice President and Chief Ethics Officer, Kathleen M. Whalen, sold 1,474 shares of common stock at a price of $357.99 per share on November 14, 2024.

Summary

• Kathleen M. Whalen, a Senior Vice President and Chief Ethics Officer at HCA Healthcare, sold 1,474 shares of the company's common stock.
• The transaction occurred on November 14, 2024.
• The sale price was $357.99 per share.
• Following the transaction, Ms. Whalen directly owns 9,454 shares of HCA Healthcare common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by an executive, with no inherent positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States, ensuring transparency of insider trading.
• The sale by Ms. Whalen is similar to other executive stock transactions at comparable companies, such as Tenet Healthcare or Community Health Systems, where executives regularly buy and sell shares.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance.

Key Dates

Keywords

HCA Healthcare, Kathleen M. Whalen, stock sale, insider trading, Form 4, executive transaction